• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘患者动脉血中白三烯B4水平及泼尼松龙的作用

Leukotriene B4 levels in the arterial blood of asthmatic patients and the effects of prednisolone.

作者信息

Shindo K, Fukumura M, Miyakawa K

机构信息

First Department of Internal Medicine, Yokohama City University School of Medicine, Japan.

出版信息

Eur Respir J. 1995 Apr;8(4):605-10.

PMID:7664862
Abstract

Prednisolone is very effective in controlling wheezing attacks of bronchial asthma, but its mechanism and the pathogenic role of leukotriene B4 remain unclear. We measured changes in plasma levels of leukotriene B4 in an open study during the clinical course of bronchial asthma, with or without water-soluble prednisolone treatment. Two millilitres of blood was drawn from the radial artery of patients on three occasions: 1) during remission; 2) on admission to hospital with an asthma attack; and 3) 2 days after admission and treatment with intravenous prednisolone (1,000 mg.day-1). Leukotriene B4 was detected by chromatographic fractionation and radioimmunoassay. In 11 asthmatic patients, leukotriene B4 levels on the three occasions were 26.8 (10.7), 106.0 (39.9) and 51.6 (20.2) pg.ml-1 (mean (SD)), respectively. In contrast, the mean leukotriene B4 level of 10 normal controls was 35.9 (10.5) pg.ml-1. Leukotriene B4 levels differed significantly between remission and attack treated without prednisolone, and between attacks treated with and without prednisolone. Mean arterial carbon dioxide (PaCO2) values were 4.8 (0.4) kPa (36.0 (3.0) mmHg), 6.1 (0.4) kPa (45.6 (2.9) mmHg), and 5.5 (0.3) kPa (41.6 (2.0) mmHg), respectively. There were significant differences between these mean PaCO2 values. The mean leukotriene B4 levels on the three occasions were correlated with the mean PaCO2 values. Thus, leukotriene B4 levels in arterial blood reflect the severity of asthmatic attacks and may be affected by intravenous prednisolone.

摘要

泼尼松龙在控制支气管哮喘的喘息发作方面非常有效,但其机制以及白三烯B4的致病作用仍不清楚。在一项开放性研究中,我们在支气管哮喘的临床过程中,测量了接受或未接受水溶性泼尼松龙治疗的患者血浆白三烯B4水平的变化。在三个时间点从患者的桡动脉抽取2毫升血液:1)缓解期;2)因哮喘发作入院时;3)入院并接受静脉注射泼尼松龙(1000毫克/天)治疗2天后。通过色谱分离和放射免疫测定法检测白三烯B4。11例哮喘患者在这三个时间点的白三烯B4水平分别为26.8(10.7)、106.0(39.9)和51.6(20.2)皮克/毫升(平均值(标准差))。相比之下,10名正常对照者的白三烯B4平均水平为35.9(10.5)皮克/毫升。未用泼尼松龙治疗的缓解期与发作期之间以及用与不用泼尼松龙治疗的发作期之间,白三烯B4水平存在显著差异。平均动脉二氧化碳(PaCO2)值分别为4.8(0.4)千帕(36.0(3.0)毫米汞柱)、6.1(0.4)千帕(45.6(2.9)毫米汞柱)和5.5(0.3)千帕(41.6(2.0)毫米汞柱)。这些平均PaCO2值之间存在显著差异。这三个时间点的白三烯B4平均水平与平均PaCO2值相关。因此,动脉血中的白三烯B4水平反映了哮喘发作的严重程度,并可能受静脉注射泼尼松龙的影响。

相似文献

1
Leukotriene B4 levels in the arterial blood of asthmatic patients and the effects of prednisolone.哮喘患者动脉血中白三烯B4水平及泼尼松龙的作用
Eur Respir J. 1995 Apr;8(4):605-10.
2
Plasma levels of leukotriene B4 in asthmatic patients.哮喘患者血浆白三烯B4水平
Int J Tissue React. 1993;15(5):181-4.
3
Plasma levels of leukotriene E4 during clinical course of bronchial asthma and the effect of oral prednisolone.支气管哮喘临床病程中白三烯E4的血浆水平及口服泼尼松龙的作用
Chest. 1994 Apr;105(4):1038-41. doi: 10.1378/chest.105.4.1038.
4
Blood levels of leukotrienes (LTC4, D4, E4, B4) in asthmatic patients during attack and remission.
Arerugi. 1994 Jan;43(1):28-36.
5
Measurement of leukotriene B4 in arterial blood of asthmatic patients during wheezing attacks.哮喘患者喘息发作时动脉血中白三烯B4的测定。
J Intern Med. 1990 Aug;228(2):91-6. doi: 10.1111/j.1365-2796.1990.tb00200.x.
6
In vivo effect of prednisolone on release of leukotriene B4 from neutrophils from asthmatic patients.泼尼松龙对哮喘患者中性粒细胞白三烯B4释放的体内作用。
Biochem Biophys Res Commun. 1996 May 24;222(3):759-63. doi: 10.1006/bbrc.1996.0817.
7
Comparison of serum and plasma leukotriene B4 levels in normal and asthmatic subjects.正常人和哮喘患者血清与血浆白三烯B4水平的比较。
Ann Allergy Asthma Immunol. 1995 Oct;75(4):365-8.
8
Measurement of leukotriene C4 and D4 in arterial blood of asthmatic patients during remission.缓解期哮喘患者动脉血中白三烯C4和D4的测定。
Ann Allergy. 1991 May;66(5):405-10.
9
Detection of leukotrienes in the serum of asthmatic and psoriatic patients.哮喘和银屑病患者血清中白三烯的检测
Acta Derm Venereol. 1986;66(5):381-5.
10
In vivo effect of prednisolone on release of leukotriene C4 in eosinophils obtained from asthmatic patients.泼尼松龙对从哮喘患者获取的嗜酸性粒细胞中白三烯C4释放的体内作用。
Biochem Biophys Res Commun. 1995 Sep 25;214(3):869-74. doi: 10.1006/bbrc.1995.2367.

引用本文的文献

1
STC-1 alleviates airway inflammation by regulating epithelial cell apoptosis through the 5-LO pathway.STC-1通过5-脂氧合酶途径调节上皮细胞凋亡来减轻气道炎症。
Inflammation. 2024 Nov 15. doi: 10.1007/s10753-024-02181-5.
2
LTA4H rs2660845 association with montelukast response in early and late-onset asthma.LTA4H rs2660845 与早发和晚发哮喘中孟鲁司特反应的相关性。
PLoS One. 2021 Sep 22;16(9):e0257396. doi: 10.1371/journal.pone.0257396. eCollection 2021.
3
Leukotriene A4 Hydrolase Activation and Leukotriene B4 Production by Eosinophils in Severe Asthma.
严重哮喘中嗜酸性粒细胞的白三烯 A4 水解酶激活和白三烯 B4 产生。
Am J Respir Cell Mol Biol. 2019 Apr;60(4):413-419. doi: 10.1165/rcmb.2018-0175OC.
4
Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma.白三烯 B4-BLT1 和 LTB4-BLT2 途径在哮喘中的重要性。
Semin Immunol. 2017 Oct;33:44-51. doi: 10.1016/j.smim.2017.08.005.
5
Expression of functional leukotriene B4 receptors on human airway smooth muscle cells.功能性白三烯B4受体在人气道平滑肌细胞上的表达。
J Allergy Clin Immunol. 2009 Jul;124(1):59-65.e1-3. doi: 10.1016/j.jaci.2009.03.024. Epub 2009 May 27.
6
Phosphorylation of serine 271 on 5-lipoxygenase and its role in nuclear export.5-脂氧合酶丝氨酸271位点的磷酸化及其在细胞核输出中的作用。
J Biol Chem. 2009 Jan 2;284(1):306-313. doi: 10.1074/jbc.M805593200. Epub 2008 Nov 1.
7
Expression of 5-lipoxygenase in specialized epithelial cells of nasopharyngeal-associated lymphoid tissue.5-脂氧合酶在鼻咽相关淋巴组织特化上皮细胞中的表达。
J Mol Histol. 2005 Oct;36(8-9):475-81. doi: 10.1007/s10735-006-9022-0. Epub 2006 Apr 28.
8
The measurement of leukotrienes in human fluids.人体体液中白三烯的测量。
Clin Rev Allergy Immunol. 1999 Spring-Summer;17(1-2):153-77. doi: 10.1007/BF02737602.